Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides
Open Access
- 16 October 2006
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 6 (1) , 150
Abstract
Evaluation of microbicides for prevention of HIV-1 infection in macaque models for vaginal infection has indicated that the concentrations of active compounds needed for protection by far exceed levels sufficient for complete inhibition of infection in vitro. These experiments were done in the absence of seminal plasma (SP), a vehicle for sexual transmission of the virus. To gain insight into the possible effect of SP on the performance of selected microbicides, their anti-HIV-1 activity in the presence, and absence of SP, was determined. The inhibitory activity of compounds against the X4 virus, HIV-1 IIIB, and the R5 virus, HIV-1 BaL was determined using TZM-bl indicator cells and quantitated by measuring β-galactosidase induced by infection. The virucidal properties of cellulose acetate 1,2-benzene-dicarboxylate (CAP), the only microbicide provided in water insoluble, micronized form, in the presence of SP was measured. The HIV-1 inhibitory activity of the polymeric microbicides, poly(naphthalene sulfonate), cellulose sulfate, carrageenan, CAP (in soluble form) and polystyrene sulfonate, respectively, was considerably (range ≈ 4 to ≈ 73-fold) diminished in the presence of SP (33.3%). Formulations of micronized CAP, providing an acidic buffering system even in the presence of an SP volume excess, effectively inactivated HIV-1 infectivity. The data presented here suggest that the in vivo efficacy of polymeric microbicides, acting as HIV-1 entry inhibitors, might become at least partly compromised by the inevitable presence of SP. These possible disadvantages could be overcome by combining the respective polymers with acidic pH buffering systems (built-in for formulations of micronized CAP) or with other anti-HIV-1 compounds, the activity of which is not affected by SP, e.g. reverse transcriptase and zinc finger inhibitors.Keywords
This publication has 51 references indexed in Scilit:
- Biocompatibility of Solid-Dosage Forms of Anti-Human Immunodeficiency Virus Type 1 Microbicides with the Human Cervicovaginal Mucosa Modeled Ex VivoAntimicrobial Agents and Chemotherapy, 2006
- Cellulose Acetate 1,2-Benzenedicarboxylate Inhibits Infection by Cell-Free and Cell-Associated Primary HIV-1 IsolatesAIDS Research and Human Retroviruses, 2006
- Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety studyAIDS, 2006
- In Vitro and in Vivo Characterization of a Potential Universal Placebo Designed for Use in Vaginal Microbicide Clinical TrialsAIDS Research and Human Retroviruses, 2005
- SPL7013 Gel as a Topical Microbicide for Prevention of Vaginal Transmission of SHIV 89.6P in MacaquesAIDS Research and Human Retroviruses, 2005
- Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman PrimatesThe Journal of Infectious Diseases, 2005
- Inhibiting sexual transmission of HIV-1 infectionNature Reviews Microbiology, 2003
- Design of a “Microbicide” for Prevention of Sexually Transmitted Diseases Using “Inactive” Pharmaceutical ExcipientsBiologicals, 1999
- Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope GlycoproteinAIDS Research and Human Retroviruses, 1988
- Inactivation of Myxoviruses by Oxidized PolyaminesJournal of General Virology, 1971